Review Article

The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis

Table 2

Subgroup analysis based on different definitions of Tregs in PB of patients with AS.

Definition of TregsNumber of studiesTest of associationTest of heterogeneityEgger’s test
SMD95% CI value value value

Single CD25-positive60.736(0.138, 1.334)0.01680.7%<0.0010.720.513
 CD4+CD25+10.846(0.401, 1.291)<0.001
 CD4+CD25high40.892(−0.078, 1.862)0.07187%<0.0012.740.112
 CD4+CD25bright10.123(−0.596, 0.842)0.737
Associated with FOXP3-positive18−1.004(−1.966, −0.042)0.04197.9%<0.0010.970.795
 CD4+FOXP3+30.383(−0.663, 1.429)0.47390.4%<0.001−11.620.143
 CD4+CD25+FOXP3+9−2.856(−4.645, −1.066)0.00298.6%<0.0016.060.42
 CD4+CD25highFOXP3+30.868(−0.756, 2.492)0.29592.6%<0.0012.910.862
 CD4+CD25low/−FOPX3+30.683(0.161, 1.206)0.0168.4%0.0429.580.783
Associated with CD127-negative4−1.003(−1.713, −0.294)0.00673.1%0.011−0.370.747
 CD4+CD25highCD127low/−1−1.812(−2.648, −0.977)<0.001
 CD4+CD25+CD127low2−1.12(−1.605, −0.635)<0.0010.0%0.486
 CD4+CD25+CD1271−0.004(−0.751, 0.744)0.992

PB: peripheral blood; AS: ankylosing spondylitis; SMD: standard mean difference; CI: confidence interval; : -squared index. Magnitude of Cohen’s effect size (SMD): 0.2–0.5, small effect; 0.5–0.8, medium effect; and ≥0.8, large effect.